[
  {
    "ts": null,
    "headline": "BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance",
    "summary": "McKesson Corporation (NYSE:MCK) is one of the best performing S&P 500 stocks in the last five years. On February 5, 2026, BofA reaffirmed its ‘Buy’ rating on McKesson Corporation (NYSE:MCK) and increased its price target from $950 to $970. Describing the third quarter as strong, the firm pointed to revenue and EPS, both of which […]",
    "url": "https://finnhub.io/api/news?id=02e1ffe9976199a3f6c21f5dd2e3c5f28c1b66642c02156c4e239d302081d0fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770837989,
      "headline": "BofA Remains Bullish on McKesson (MCK) Following Strong Third Quarter Performance",
      "id": 139048128,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "McKesson Corporation (NYSE:MCK) is one of the best performing S&P 500 stocks in the last five years. On February 5, 2026, BofA reaffirmed its ‘Buy’ rating on McKesson Corporation (NYSE:MCK) and increased its price target from $950 to $970. Describing the third quarter as strong, the firm pointed to revenue and EPS, both of which […]",
      "url": "https://finnhub.io/api/news?id=02e1ffe9976199a3f6c21f5dd2e3c5f28c1b66642c02156c4e239d302081d0fd"
    }
  },
  {
    "ts": null,
    "headline": "McKesson (MCK) Is Up 9.9% After Strong Q3 Earnings, Capital Returns And New Shelf Filing – Has The Bull Case Changed?",
    "summary": "Earlier this month, McKesson reported third-quarter fiscal 2026 results showing sales of US$106.16 billion and net income of US$1.19 billion, with earnings per share from continuing operations increasing compared with the same period a year ago. The company also continued to return cash to shareholders, repurchasing 800,000 shares in the latest quarter and declaring an US$0.82 quarterly dividend, while filing an omnibus shelf registration that gives it flexibility to issue a wide range of...",
    "url": "https://finnhub.io/api/news?id=d04eb336e4ebcfb11087642947fe8e76c1dfbd721890c3cb3d6647eb7223026a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770836909,
      "headline": "McKesson (MCK) Is Up 9.9% After Strong Q3 Earnings, Capital Returns And New Shelf Filing – Has The Bull Case Changed?",
      "id": 139048129,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Earlier this month, McKesson reported third-quarter fiscal 2026 results showing sales of US$106.16 billion and net income of US$1.19 billion, with earnings per share from continuing operations increasing compared with the same period a year ago. The company also continued to return cash to shareholders, repurchasing 800,000 shares in the latest quarter and declaring an US$0.82 quarterly dividend, while filing an omnibus shelf registration that gives it flexibility to issue a wide range of...",
      "url": "https://finnhub.io/api/news?id=d04eb336e4ebcfb11087642947fe8e76c1dfbd721890c3cb3d6647eb7223026a"
    }
  },
  {
    "ts": null,
    "headline": "McKesson Corp. stock outperforms competitors on strong trading day",
    "summary": "McKesson Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=297481f16915e8de5ddf9fe1291664235adbea0357e89094d4216cfc599985e3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770827880,
      "headline": "McKesson Corp. stock outperforms competitors on strong trading day",
      "id": 139062506,
      "image": "",
      "related": "MCK",
      "source": "MarketWatch",
      "summary": "McKesson Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=297481f16915e8de5ddf9fe1291664235adbea0357e89094d4216cfc599985e3"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Allogene Therapeutics (ALLO) This Year?",
    "summary": "Here is how Allogene Therapeutics (ALLO) and McKesson (MCK) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=33ace32fdfd1d447bc1d3a9eefea7688982a7e342eb7026050e35d92f4f08536",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770820804,
      "headline": "Are Medical Stocks Lagging  Allogene Therapeutics (ALLO) This Year?",
      "id": 139046533,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Here is how Allogene Therapeutics (ALLO) and McKesson (MCK) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=33ace32fdfd1d447bc1d3a9eefea7688982a7e342eb7026050e35d92f4f08536"
    }
  },
  {
    "ts": null,
    "headline": "McKesson (MCK) Valuation Check After Strong Multi‑Period Share Price Momentum",
    "summary": "McKesson (MCK) is on many investors’ screens after its recent share move, with the stock closing at $935.21 and showing double digit total returns over the past year and the past 3 months. See our latest analysis for McKesson. That recent run, including a 9.9% 7 day share price return and 14.6% 30 day share price return, sits alongside a 1 year total shareholder return of 53.9% and a very large 5 year total shareholder return. Taken together, these figures point to strong momentum rather than...",
    "url": "https://finnhub.io/api/news?id=99d5158e79ea488dc0e40f966305c8e1fdc4a496528b18f6aaa8abd95dd5eada",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770811979,
      "headline": "McKesson (MCK) Valuation Check After Strong Multi‑Period Share Price Momentum",
      "id": 139042345,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "McKesson (MCK) is on many investors’ screens after its recent share move, with the stock closing at $935.21 and showing double digit total returns over the past year and the past 3 months. See our latest analysis for McKesson. That recent run, including a 9.9% 7 day share price return and 14.6% 30 day share price return, sits alongside a 1 year total shareholder return of 53.9% and a very large 5 year total shareholder return. Taken together, these figures point to strong momentum rather than...",
      "url": "https://finnhub.io/api/news?id=99d5158e79ea488dc0e40f966305c8e1fdc4a496528b18f6aaa8abd95dd5eada"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Analyst Repricing Is Shaping The Story Behind McKesson (MCK)",
    "summary": "McKesson’s recent price target reset reflects small but meaningful tweaks to the story the market is telling about the stock. Fair value is moving from about US$942 to roughly US$966, and the discount rate is shifting from 6.956% to 6.978%. Revenue growth assumptions have been updated from 8.47% to 8.05%, hinting that analysts are refining their models around cash flow and risk rather than rewriting the entire outlook. As you read on, you will see how these kinds of adjustments shape the...",
    "url": "https://finnhub.io/api/news?id=2edf8103d5d1c3712a380555aebe90bda6d7849a7d75e0f47f03cd9226351eb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770797622,
      "headline": "How Recent Analyst Repricing Is Shaping The Story Behind McKesson (MCK)",
      "id": 139040503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "McKesson’s recent price target reset reflects small but meaningful tweaks to the story the market is telling about the stock. Fair value is moving from about US$942 to roughly US$966, and the discount rate is shifting from 6.956% to 6.978%. Revenue growth assumptions have been updated from 8.47% to 8.05%, hinting that analysts are refining their models around cash flow and risk rather than rewriting the entire outlook. As you read on, you will see how these kinds of adjustments shape the...",
      "url": "https://finnhub.io/api/news?id=2edf8103d5d1c3712a380555aebe90bda6d7849a7d75e0f47f03cd9226351eb2"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call",
    "summary": "McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed the growth to robust performance in oncology, expanded biopharma services, and continued momentum in North American pharmaceutical distribution. CEO Brian Tyler specifically highlighted the integration of recent acquisitions such as Florida Cancer Specialists and Prism Vision as meaningful contributo",
    "url": "https://finnhub.io/api/news?id=e44b3e985ab63f70bac746f3217d3edada791100b1037d88b38c32e45847dc9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770788255,
      "headline": "5 Insightful Analyst Questions From McKesson’s Q4 Earnings Call",
      "id": 139042346,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "McKesson’s fourth-quarter results met Wall Street’s revenue expectations and modestly exceeded consensus for non-GAAP earnings per share, with the market responding positively. Management attributed the growth to robust performance in oncology, expanded biopharma services, and continued momentum in North American pharmaceutical distribution. CEO Brian Tyler specifically highlighted the integration of recent acquisitions such as Florida Cancer Specialists and Prism Vision as meaningful contributo",
      "url": "https://finnhub.io/api/news?id=e44b3e985ab63f70bac746f3217d3edada791100b1037d88b38c32e45847dc9d"
    }
  }
]